Chart calendar Neurocrine Biosciences, Inc.

b826.Q21qSlK97WVKX_hV8yYJfBvg0O8XSOdagZOaTX50ssI.JCcjCWDLtAIfMZ8ni1NmM2m5o6NdLJ8isNbUfTIF0YQ3NV88GNmKMy0qyA~d4051470194da2eda394325781179ec4

Upcoming events on Neurocrine Biosciences, Inc.

01/08/2024 04:30 pm Q2 2024 Earnings Release
01/08/2024 05:30 pm Q2 2024 Earnings Call
29/10/2024 Q3 2024 Earnings Release (Projected)
11/02/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)
05/08/2025 Q2 2025 Earnings Release (Projected)

Past events on Neurocrine Biosciences, Inc.

13/06/2024 08:10 pm Goldman Sachs Global Healthcare Conference
06/06/2024 12:00 am Jefferies Global Healthcare Conference
22/05/2024 11:00 pm Annual General Meeting
14/05/2024 11:50 pm BofA Securities Health Care Conference
11/05/2024 06:00 pm American Association of Clinical Endocrinology Meeting - Abstract No:05
10/05/2024 09:30 pm American Association of Clinical Endocrinology Meeting
10/05/2024 08:40 pm American Association of Clinical Endocrinology Meeting - Abstract No:14
01/05/2024 05:30 pm Q1 2024 Earnings Call
01/05/2024 04:30 pm Q1 2024 Earnings Release
19/03/2024 11:30 pm Stifel Virtual CNS Conference
18/03/2024 09:30 pm UBS Virtual CNS Day
13/03/2024 07:45 pm Barclays Global Healthcare Conference
12/03/2024 06:10 pm Leerink Partners Global Biopharma Conference
05/03/2024 09:40 pm TD Cowen Health Care Conference
07/02/2024 06:30 pm Q4 2023 Earnings Call
07/02/2024 05:30 pm Q4 2023 Earnings Release
09/01/2024 11:15 pm JPMorgan Healthcare Conference
05/12/2023 11:30 pm Analyst Day
14/11/2023 08:30 pm Jefferies London Healthcare Conference
09/11/2023 NEI Congress

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million USD
Released
Forecast
Spread
1 134
1 139
-0.47%
1 489
1 484
0.31%
1 887
1 885
0.1%

2 220


2 550


2 971

EBITDA
Million USD
Released
Forecast
Spread
131
232
-43.66%
264
336
-21.3%
269
281
-4.33%

561


847


1 107

EBIT
Million USD
Released
Forecast
Spread
103
209
-51.06%
249
289
-13.9%
251
258
-2.84%

566


824


1 128

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
101
181
-43.99%
214
241
-11.43%
332
296
12.11%

546


869


1 179

Net income
Million USD
Released
Forecast
Spread
89,6
148
-39.37%
155
188
-17.63%
250
225
11.11%

433


673


913

EPS
USD
Released
Forecast
Spread
0,92
1,51
-39.1%
1,56
1,88
-17.15%
2,47
2,22
11.3%

4,08


6,33


8,69

Announcement Date11/02/2206/02/2307/02/24-

Quarterly results

Fiscal PeriodMarzo 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
378
343
10.12%
388
377
2.96%
412
409
0.74%
420
409
2.78%
453
448
1.05%
499
479
4.13%
515
518
-0.62%
515
512
0.64%

548


569


590


588


616


648


677

EBITDA
Million USD
Released
Forecast
Spread
59,0
75,6
-21.96%
91,8
109
-16.04%
107
155
-30.67%
-109
42,8
-355.18%
78,7
126
-37.5%
144
147
-1.74%
155
149
4.23%
106
127
-16.67%

146


159


136













EBIT
Million USD
Released
Forecast
Spread
54,7
66,7
-17.94%
87,8
96,8
-9.28%
103
136
-23.91%
-114
14,7
-874.64%
73,6
99,5
-26.06%
141
125
12.9%
150
154
-2.64%
99,3
118
-15.82%

145


163


173


131


166


207


267

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-23,3
61,7
-137.75%
97,9
89,2
9.71%
118
135
-12.69%
-103
33,1
-412.49%
122
98,0
24.07%
116
132
-12.2%
198
159
24.47%
34,5
129
-73.3%

138


177


186


142


178


220


281

Net income
Million USD
Released
Forecast
Spread
-16,9
58,1
-129.08%
68,5
76,2
-10.08%
89,0
118
-24.66%
-76,6
8,27
-1026.71%
95,5
75,4
26.62%
83,1
97,8
-15.04%
148
115
28.34%
43,4
101
-57.11%

114


135


149


109


137


169


217

EPS
USD
Released
Forecast
Spread
-0,18
0,62
-128.85%
0,69
0,79
-13.19%
0,88
1,15
-23.33%
-0,79
0,04
-2143.98%
0,95
0,77
23.93%
0,82
0,97
-15.1%
1,44
1,12
28.46%
0,42
1,00
-57.99%

1,03


1,25


1,32


1,18


1,40


1,63


1,67

Announcement Date04/08/2201/11/2206/02/2303/05/2301/08/2331/10/2307/02/2401/05/24-------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. Calendar Neurocrine Biosciences, Inc.